B2DB — Who said what, where, and when

Scott H. Altern, Ph.D.

Senior Scientist II, AbbVie

Scott H. Altern, Ph.D. is listed as Senior Scientist II, AbbVie. Scott is scheduled to speak at BPI West 2027 on 17 March 2027.

Compiled from published conference agendas; not yet confirmed by Scott. Is this you? Claim this profile.

About

Scott H. Altern is a Senior Scientist II at AbbVie Bioresearch Center in Worcester, MA, working in purification development. He graduated from Rensselaer Polytechnic Institute in 2023 with a PhD in Chemical and Biological Engineering from Prof. Steven Cramer's group, specializing in mechanistic modeling of multimodal chromatography. Since then, Scott has driven the development and implementation of mechanistic modeling at AbbVie for both early- and late-stage biologics pipelines. His efforts have enabled multiple IND and BLA filings, enabling accelerated timelines and reduced cost of process development and process characterization for mAbs and complex multispecifics. Scott has also driven the use of high-throughput screening for process development, including its synchronous use with mechanistic modeling. Beyond modeling, he has led multiple FIH programs in process development, tech transfer, viral clearance studies, and IND authoring – demonstrating himself as a versatile contributor

Upcoming

BPI West 2027 16 March 2027 – 18 March 2027